Motivational Strategies To Empower African Americans To Improve Dialysis Adherence (MoVE)

  • STATUS
    Recruiting
  • days left to enroll
    28
  • participants needed
    30
  • sponsor
    Vanderbilt University Medical Center
Updated on 14 July 2022

Summary

This study addresses the need to rigorously advance the science and understanding of the development, feasibility, acceptability and adoption of novel culturally-sensitive motivational strategies to improve dialysis treatment adherence among African Americans with end-stage kidney disease (ESKD). This study specifically aims to:

  1. Gain advanced skills in the development and implementation of novel culturally sensitive motivational strategies
  2. Acquire critical preliminary data for an R01-funded phase II efficacy trial testing the use of these motivational strategies to improve dialysis treatment adherence.

Details
Condition End Stage Renal Disease on Dialysis
Treatment Motivational Interviewing
Clinical Study IdentifierNCT05003115
SponsorVanderbilt University Medical Center
Last Modified on14 July 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

African American
Receiving hemodialysis treatments
Been on hemodialysis for more than 30 days
years of age and older
Within a 3-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes

Exclusion Criteria

Not self-identified as African American
Impaired with mental status or severe illness
Non-English speaking
No documented evidence of dialysis treatment non-adherence
Missed or shortened treatments due to hospitalizations or excused travel
Terminal condition
Living in a nursing home/rehab
Planned transplant within the next 3 months
Planned conversion to peritoneal dialysis within the next 3 months
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note